Robert Michael Dudley is Chief Executive Officer of TransCode Therapeutics Inc.
Person profile
Roles
TransCode Therapeutics
Chief Executive Officer
Address
Boston, Massachusetts
Employees
SEC CIK
Latest filings (excl ownership)
No filings
Latest ownership filings
SC 13D/A
Transcode Therapeutics, Inc.
10 Oct 23
4
Transcode Therapeutics, Inc.
2 Oct 23
4
Transcode Therapeutics, Inc.
22 Jun 23
SC 13D/A
Transcode Therapeutics, Inc.
16 Jun 23
4/A
Transcode Therapeutics, Inc.
14 Jun 23
4
Transcode Therapeutics, Inc.
13 Jun 23
4
Transcode Therapeutics, Inc.
19 May 23
SC 13D
Transcode Therapeutics, Inc.
20 Dec 22
SC 13G
Transcode Therapeutics, Inc.
20 Dec 22
4
Transcode Therapeutics, Inc.
14 Dec 22
Recent insider trades
Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
28 Sep 23 | RNAZ TransCode Therapeutics | Common Stock | Buy | Acquire P | No | No | 0.51 | 98,000 | 49.98 k | 180,262 |
21 Jun 23 | RNAZ TransCode Therapeutics | Common Stock | Buy | Acquire P | No | No | 2.6515 | 12,000 | 31.82 k | 82,262 |
20 Jun 23 | RNAZ TransCode Therapeutics | Common Stock | Buy | Acquire P | No | No | 2.5498 | 6,607 | 16.85 k | 70,262 |
9 Jun 23 | RNAZ TransCode Therapeutics | Common Stock | Buy | Acquire P | No | No | 2.76 | 19,000 | 52.44 k | 61,155 |
9 Jun 23 | RNAZ TransCode Therapeutics | Common Stock | Buy | Acquire P | No | No | 2.76 | 19,000 | 52.44 k | 912,114 |
19 May 23 | RNAZ TransCode Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 0.2834 | 735,000 | 208.30 k | 735,000 |